Cas:145739-56-6 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid manufacturer & supplier

Chemical Name:6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid

CAS.NO:145739-56-6

Synonyms:Tetomilast;2-Pyridinecarboxylic acid, 6-[5-(3,4-diethoxyphenyl)-3-thienyl]-;UNII-S6RXB5KF56;6-[5-(3,4-Diethoxyphenyl)-3-thienyl]-2-pyridinecarboxylic acid;6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid

Molecular Formula:C₂₀H₁₉NO₄S

Molecular Weight:369.434

HS Code:2934100090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:526.1±50.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.601

PSA:109.78000

Exact Mass:369.103485

LogP:4.39

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Tetomilast chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetomilast Use and application,Tetomilast technical grade,usp/ep/jp grade.

Related News: Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid manufacturer The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid supplier The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid factory Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.